S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q4 2022

Baker Bros Advisors

Periodo: Q4 2022 Β· Depositato: 2023-02-14
Vedi su SEC EDGAR β†—
AUM
$16.65B
Valore totale del portafoglio
Posizioni
113
Titoli dichiarati
Prima Posizione
SGEN
36.2% $6.03B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$6.03B36.21%β€”β€”
36.2%
INCYIncyte Corporation$2.90B17.44%$79.55$116.86+46.9%
17.4%
ONCBeiGene, Ltd.$2.57B15.41%$226.63$297.65+31.3%
15.4%
BMRNBioMarin Pharmaceutical Inc.$788.6M4.74%$100.61$58.99-41.4%
4.7%
ACADACADIA Pharmaceuticals Inc.$667.4M4.01%$16.32$25.97+59.1%
4.0%
ASNDAscendis Pharma A/S$605.1M3.63%$120.72$274.50+127.4%
3.6%
MDGLMadrigal Pharmaceuticals, Inc.$448.5M2.69%$285.42$528.10+85.0%
2.7%
RYTMRhythm Pharmaceuticals, Inc.$185.1M1.11%$28.64$114.17+298.6%
1.1%
BCRXBioCryst Pharmaceuticals, Inc.$145.9M0.88%$11.45$9.84-14.1%
0.9%
IMCRImmunocore Holdings plc$143.9M0.86%$55.42$32.50-41.4%
0.9%
AKROAkero Therapeutics, Inc.$129.8M0.78%β€”β€”
0.8%
REPLReplimune Group, Inc.$124.5M0.75%$26.35$11.58-56.0%
0.8%
KODKodiak Sciences Inc.$123.9M0.74%$7.77$38.54+396.0%
0.7%
HZNPHorizon Therapeutics Public Ltd Co$110.3M0.66%β€”β€”
0.7%
ARGXargenx SE$106.1M0.64%$373.80$939.68+151.4%
0.6%
ABCLAbCellera Biologics Inc.$105.9M0.64%$9.49$8.11-14.5%
0.6%
KYMRKymera Therapeutics, Inc.$71.9M0.43%$24.84$113.51+357.0%
0.4%
KDNYChinook Therapeutics, Inc.$66.4M0.40%β€”β€”
0.4%
TRDAEntrada Therapeutics, Inc.$65.8M0.40%$13.44$7.72-42.6%
0.4%
MRTXMirati Therapeutics, Inc.$63.9M0.38%β€”β€”
0.4%
PRLDPrelude Therapeutics Inc.$61.1M0.37%$5.02$4.91-2.2%
0.4%
CERSCerus Corporation$58.6M0.35%$3.74$3.16-15.5%
0.3%
AVTEAerovate Therapeutics, Inc.$57.9M0.35%β€”β€”
0.3%
IGMSIGM Biosciences, Inc.$53.7M0.32%β€”β€”
0.3%
IMTXImmatics N.V.$45.2M0.27%$8.57$9.95+16.1%
0.3%
NRIXNurix Therapeutics, Inc.$42.6M0.26%$10.85$23.97+120.9%
0.3%
KNSAKiniksa Pharmaceuticals, Ltd.$41.9M0.25%$14.44$64.53+346.9%
0.3%
SWTXSpringWorks Therapeutics, Inc.$39.8M0.24%β€”β€”
0.2%
IDYAIDEAYA Biosciences, Inc.$30.3M0.18%$17.38$37.65+116.6%
0.2%
DNLIDenali Therapeutics Inc.$30.3M0.18%$27.63$25.83-6.5%
0.2%

AttivitΓ  Trimestre su Trimestre

Q4 2022 vs. Q3 2022

Nuove Posizioni (8)

TickerEmittenteNozionale
SWTXSpringWorks Therapeutics, Inc.$39.8M
PRMEPrime Medicine, Inc.$19.1M
SPRYARS Pharmaceuticals, Inc.$17.1M
ZYMEZymeworks Inc.$13.4M
RNAMAvidity Biosciences, Inc.$9.7M
SMMTSummit Therapeutics Inc.$8.5M
CMPXCompass Therapeutics, Inc.$7.8M
BHVNBiohaven Ltd.$6.6M

Posizioni Chiuse (8)

TickerEmittenteNozionale
GBTGlobal Blood Therapeutics, Inc.$254.2M
CCXIChemoCentryx, Inc.$92.6M
FMTXForma Therapeutics Holdings, Inc.$37.6M
RLMDRelmada Therapeutics, Inc.$18.3M
ALKSAlkermes plc$18.2M
CRNXCrinetics Pharmaceuticals, Inc.$14.4M
TCDAQTricida, Inc.$13.8M
ZYMEZymeworks Inc.$10.5M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
IPSCCentury Therapeutics, Inc.$2.2M+210.1%
STOKStoke Therapeutics, Inc.$5.5M+200.3%
ALECAlector, Inc.$4.0M+185.1%
CABACabaletta Bio, Inc.$12.0M+103.0%
DNLIDenali Therapeutics Inc.$12.2M+84.9%-6.5%
ANABAnaptysBio, Inc.$13.2M+81.6%
ATHAAthira Pharma, Inc.$2.9M+80.6%
FGENFibroGen, Inc.$11.4M+68.6%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
ATYRaTyr Pharma, Inc.$-0.6M-95.7%
ALTAltimmune, Inc.$-11.8M-63.1%
TVTXTravere Therapeutics, Inc.$-55.5M-62.9%
DSGNDesign Therapeutics, Inc.$-16.9M-51.8%
Insmed Incorporated$-17.1M-41.2%
KRYSKrystal Biotech, Inc.$-5.4M-28.3%
KRONKronos Bio, Inc.$-3.2M-22.2%
CYTTCyteir Therapeutics, Inc.$-1.0M-5.7%
← Torna agli Hedge Fund